Advancing medical science through cutting-edge research and clinical trials.
We are a leading force in advancing medical research and healthcare innovation. Dedicated to conducting cutting-edge clinical trials that drive progress, improve patient outcomes, and shape the future of medicine.
Our experienced team ensures that trials are conducted with the utmost rigor, compliance, and ethical standards while prioritizing the safety and well-being of all participants.
| Sponsor | Protocol | Study Purpose |
|---|---|---|
| Biogen | Envision | Verify the clinical benefit of aducanumab compared with placebo in participants with Alzheimer's disease. |
| Ipsen Pharma | DIRECTION | Compare the safety and efficacy of onabotulinumtoxinA and abobotulinumtoxinA in treating upper limb spasticity. |
| Novartis | COMB157GUS10 | Assess the effect of ofatumumab 20mg SC monthly in early MS patient population with clinical and MRI efficacy. |
| American College of Radiology | NCT04426539 | Compare 12-month health outcomes in amyloid PET-positive versus amyloid PET-negative individuals with MCI and dementia. |
Potentially access cutting-edge treatments before they become widely available.
Receive close medical supervision from experienced research professionals.
Help advance medical knowledge and benefit future patients.
Research-related care and monitoring are typically provided at no cost.
Dr. Patricio Espinosa and the Espinosa Neuroscience Institute have published several comprehensive guides to advance neurological education and patient care.
A Practical Guide to Diagnosis and Treatment of Neurological Disorders
Kindle Edition
View on AmazonHow to Care for a Loved One With Alzheimer's, Dementia, and Memory Loss
Comprehensive caregiver resource
View on Amazon